%PDF-1.6
%
1 0 obj
<>
endobj
2 0 obj
<>stream
2013-10-23T20:48:36+03:00
2013-10-23T20:48:35+03:00
2013-10-23T20:48:36+03:00
application/pdf
bs-3256R-A647
uuid:d6ff22eb-4919-45b4-9505-ab012df1c6b7
uuid:57c79e24-f6ed-4ba8-a8c3-8f5925380654
Acrobat Web Capture 9.0
endstream
endobj
5 0 obj
<>
endobj
6 0 obj
<>
endobj
3 0 obj
<>
endobj
7 0 obj
<>
endobj
11 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text/ImageC/ImageI]/XObject<>>>/Type/Page>>
endobj
12 0 obj
[33 0 R]
endobj
13 0 obj
<>stream
/CS0 cs 1 scn
10 815.997 574.5 -704.924 re
f
BT
0.2 scn
/TT0 1 Tf
6.3621 0 0 6.3621 20.8156 769.5532 Tm
(www.biossusa.com)Tj
0 -1.5 TD
(support@biossusa.com)Tj
-0.012 Tw T*
[(800.501.7654)-34( )1([DOMESTIC])]TJ
T*
[(+1.781.569.5821)-57( )1([INTERNATIONAL])]TJ
ET
q
/GS0 gs
135.5132904 0 0 -76.34552 448.9867249 810.9069824 cm
/Im0 Do
Q
BT
0 scn
/TT1 1 Tf
0 Tw 8.907 0 0 8.907 20.8156 719.9286 Tm
[(bs)-67(-)-69(3256R)-12(-)-69(A647)]TJ
/TT0 1 Tf
-0.04 Tw 6.9983 0 0 6.9983 22.088 665.2143 Tm
[(Conjugated)-58( Primary)-1( Antibodies)]TJ
/TT1 1 Tf
0 Tw 0 -1.909 TD
(Background:)Tj
/TT0 1 Tf
-0.04 Tw 0 -1.455 TD
[(Lyn)-82( \(also)-56( known)-10( as)-29( p53/56)-63( Lyn\))-63( is)-52( a)-20( membrane)-90( associated)-48( protein)-79( tyrosine)-51( kinase)-36( \(PTK\))-56( mostly)-19( expressed)-23( in)]TJ
T*
[(hemopoietic)-22( cells)-18( which)-88( is)-52( important)-88( in)-31( cellular)-65( signaling.)1( It)-20( contains)-73( an)-8( SH2)-40( and SH3)-40( domain)-25( and has)-16( been)-19( found)]TJ
0 -1.455 TD
[(to)-32( be)-12( cleaved)-46( after)-28( activation)-37( of)-48( caspases)-72( in)-31( apoptosis.)-70( A)-36( member)-82( of)-48( the)-36( Src)-77( family)-88( of)-48( PTKs,)-73( there)-60( are)-43( two)-17( known)]TJ
T*
[(isoforms)-2( for)-52( Lyn)-82( which)-88( plays)-22( an)-8( indispensable)-69( role)-69( in)-31( the)-37( Fc)-18( epsilon)-7( RI)-6( \(Fcer1\))-2( and the)-36( B)-47( cell)-10( IgM)-30( receptor)]TJ
0 -1.455 TD
[(signaling)-29( pathway)-83( and is)-52( essential)-90( for)-52( Syk)-83( activation)-37( and Lat)-7( phosphorylation)-61( after)-28( Fcer1)-40( aggregation)-14( and can)]TJ
0 -1.455 TD
[(also)-75( phosphorylate)-47( Tec)-65( on)-81( multiple)-47( residues.)-53( Lyn)-82( can)-1( also)-75( be)-12( regulated)-18( by)-40( IL2)-38( and IL3.)]TJ
/TT1 1 Tf
0 Tw 0 -1.909 TD
(Purification:)Tj
/TT0 1 Tf
-0.04 Tw 6.727 -0.091 Td
[(Was)-36( purified)-38( by)-40( Protein)-81( A)-36( and peptide)-90( affinity)-82( chromatography.)]TJ
/TT1 1 Tf
-0.02 Tw -6.727 -2 Td
[(Modification)-47( Site:)]TJ
/TT0 1 Tf
0 Tw 0 -1.636 TD
(Tyr507)Tj
/TT1 1 Tf
0 -1.909 TD
(Storage:)Tj
/TT0 1 Tf
-0.04 Tw 0 -1.455 TD
[(Aqueous)-34( buffered)-15( solution)-14( containing)-88( 100ug/ml)-73( BSA,)-42( 50%)-22( glycerol)-55( and less)-80( than)-25( 0.09%)-82( sodium)-13( azide.)-56( Store)-44( at)-50( -)]TJ
T*
[(20\260C)-18( for)-52( 12)-90( months.)-54( Protect)-73( from)-30( light.)-67( [Product)-75( without)-66( BSA)-72( and/or)-79( sodium)-13( azide)-87( is)-52( available)-70( for)-52( special)-31( order.])]TJ
/TT1 1 Tf
0 Tw 0 -1.909 TD
(Reconstitution:)Tj
/TT0 1 Tf
-0.04 Tw 0 -1.455 TD
[(If)-36( the)-36( antibody)-25( is)-52( in)-31( liquid)-13( form,)-91( no)-81( reconstitution)-78( needed.)]TJ
0 -2.909 TD
[(Reconstitution)-90( is)-52( only)-81( required)-62( for)-52( the)-37( lyophilized)-45( antibody.)-86( Please)-15( refer)-92( to)-32( the)-36( reconstitution)-78( instruction)-26( card)-10( in)]TJ
0 -1.455 TD
[(the)-37( package.)]TJ
/TT1 1 Tf
0 Tw 53.545 33.182 Td
(Size:)Tj
/TT0 1 Tf
3 -0.091 Td
(100ul)Tj
/TT1 1 Tf
-3 -2.818 Td
(Concentration:)Tj
/TT0 1 Tf
8.091 -0.091 Td
(1ug/uL)Tj
/TT1 1 Tf
-8.091 -2.818 Td
(Host:)Tj
/TT0 1 Tf
3.273 -0.091 Td
(Rabbit)Tj
/TT1 1 Tf
-3.273 -1.909 Td
(Reactivities:)Tj
0.2 scn
/TT0 1 Tf
6.3621 0 0 6.3621 396.8173 631.495 Tm
(Human,Mouse,Rat,Chicken,Dog,Pig,Bovine,Rabbit,Sheep,Guinea)Tj
-0.012 Tw 0 -1.5 TD
[(Pig,Danio)-31( )1(rerio)]TJ
0 scn
/TT1 1 Tf
0 Tw 6.9983 0 0 6.9983 396.8173 608.5914 Tm
(Application:)Tj
ET
q
10 36 575 780 re
W n
q 1 0 0 1 406.3605 591.7317 cm
0 0 m
0 1.272 -1.909 1.272 -1.909 0 c
-1.909 -1.272 0 -1.272 0 0 c
f
Q
Q
BT
/TT0 1 Tf
6.9983 0 0 6.9983 412.7226 590.1412 Tm
[(IF\(1:100)-3(-)-1(500\))]TJ
ET
q
10 36 575 780 re
W n
q 1 0 0 1 406.3605 581.5523 cm
0 0 m
0 1.272 -1.909 1.272 -1.909 0 c
-1.909 -1.272 0 -1.272 0 0 c
f
Q
Q
BT
/TT0 1 Tf
-0.04 Tw 6.9983 0 0 6.9983 412.7226 579.9618 Tm
[(Not)-1( yet)-6( tested)-8( in)-31( other)-43( applications.)-57( Optimal)-36( working)]TJ
0 -1.455 TD
[(dilutions)-48( must)-4( be)-12( determined)-86( by)-40( the)-37( end)-90( user.)]TJ
/TT1 1 Tf
-0.02 Tw -2.273 -3.818 Td
[(Antibody)-48( Type:)]TJ
/TT0 1 Tf
0 Tw 8.182 -0.091 Td
(Polyclonal)Tj
/TT1 1 Tf
-8.182 -1.909 Td
(Isotype:)Tj
0.2 scn
/TT0 1 Tf
6.3621 0 0 6.3621 438.1711 529.0648 Tm
(IgG)Tj
0 scn
/TT1 1 Tf
-0.02 Tw 6.9983 0 0 6.9983 396.8173 515.7043 Tm
[(Molecular)-1( Weight:)]TJ
0.2 scn
/TT0 1 Tf
0 Tw 6.3621 0 0 6.3621 472.5266 515.7043 Tm
(57kDa)Tj
0 scn
/TT1 1 Tf
6.9983 0 0 6.9983 396.8173 502.3438 Tm
(Note:)Tj
/TT0 1 Tf
0.021 Tw 5.7259 0 0 5.7259 396.8173 476.2591 Tm
[(For)-20( )1(research)-16( )1(use)-26( )1(only.)-91( )1(CAUTION:)-12( )1(Not)-11( )1(for)-1( )1(human)-72( )1(or)-97( )1(animal)]TJ
0 -1.333 TD
[(therapeutic)-36( )1(or)-97( )1(diagnostic)-13( )1(use.)]TJ
ET
q
/GS0 gs
540.7807312 0 0 -0.6362152 29.08638 711.6578064 cm
/Im1 Do
Q
BT
/TT0 1 Tf
0 Tw 10.1794 0 0 10.1794 15.0897 112.9817 Tm
( )Tj
ET
q
10 36 575 780 re
W n
/CS3 cs 0.302 0.306 0.333 scn
q 1 0 0 1 13.1811 697.0249 cm
0 0 m
0 1.697 -2.545 1.697 -2.545 0 c
-2.545 -1.697 0 -1.697 0 0 c
f
Q
Q
BT
/CS3 cs 0.302 0.306 0.333 scn
/TT1 1 Tf
-0.007 Tw 8.907 0 0 8.907 22.088 694.48 Tm
[(Rabbit)-50( Anti)-28(-)-69(Phospho)-42(-)-69(Lyn)-69( \(Tyr507\))-59( Polyclonal)-4( Antibody,)-47( Alexa)-2( Fluor)-69( 647)]TJ
0 Tw 0 -1.143 TD
(conjugated)Tj
ET
q
/GS0 gs
95.4319 0 0 -71.8920288 18.9069824 413.2740784 cm
/Im2 Do
Q
BT
/CS0 cs 0 scn
/TT0 1 Tf
10.1794 0 0 10.1794 18.907 332.4751 Tm
( )Tj
ET
q
/GS0 gs
95.4319 0 0 -71.8920288 141.0597992 413.2740784 cm
/Im3 Do
Q
BT
/TT0 1 Tf
10.1794 0 0 10.1794 141.0598 332.4751 Tm
( )Tj
ET
q
/GS0 gs
95.4319 0 0 -71.8920288 263.2126312 413.2740784 cm
/Im4 Do
Q
BT
/TT0 1 Tf
10.1794 0 0 10.1794 263.2126 332.4751 Tm
( )Tj
-24 -2.25 Td
( )Tj
12 0 Td
( )Tj
12 0 Td
( )Tj
-24 -2.25 Td
( )Tj
12 0 Td
( )Tj
12 0 Td
( )Tj
-0.04 Tw 6.9983 0 0 6.9983 20.1794 256.1295 Tm
[(For)-31( full)-30( size)-82( images)-63( and description)-26( please)-13( click)-31( )]TJ
/CS3 cs 0 0.6 0.8 scn
0 Tw 6.3621 0 0 6.3621 167.7807 256.1295 Tm
(HERE)Tj
/CS0 cs 0 scn
6.9983 0 0 6.9983 183.6861 256.1295 Tm
(.)Tj
ET
q
/GS0 gs
0.6362152 0 0 -572.5913696 384.729248 711.0215759 cm
/Im5 Do
Q
q
/GS0 gs
5.7259064 0 0 -38.8089752 578.7741089 149.8820343 cm
/Im6 Do
Q
endstream
endobj
14 0 obj
<>
endobj
15 0 obj
([" c \n)
endobj
26 0 obj
<>stream
Hy\E323#3
P̴,HLEK"+E+2VTD%EH# }wfwfvvc_3?{feޝ@HHHHHH*豘V]
zן)@-9.q2BÇEڂ8g "2vn>u2]/Yz \S@ 7.M&p?o9v 0'rKś-;(Au.J%% %&˶0>6`TxOzzo(VDY*AZp ËgAs^.㮌+2Ȱ$E['FC:OMCIVVDD3}`u߈buߨɴ4қԭV^V0XF ϓ@i|Y|.?i'3}Ŵ+ޘaa:
3g},F"kNɳՕx57,H)X7*v/Mո+(fWr=WӃJcߓtG16sPt:t"9G
if
3do\ˢ|c:1&<ЭWnPdq0IRgu~惘n9BWV2T6~}rs4h-D.sgV/n3;q@hThI*jTJqJK2c!QT7;60
5NoJݻ'rBP%ȍ4
P(/CJC1
9eڴ}5S{"wty@P5e*Zg~?S(Sɗ,ʽv 2[̋t_Z\d&}/2YϹO&y#
?P>,0P-
asds[U꼩\=T~)S>B,gk$7+j0?60<&uźg
A]_@en%Mȝ~5PSu$^2s0RSPw L9٦n9$vڣ=f#g 7,Oa
:ܾ.4+H!=MvF(G|YU
ITR)>@✧*[j5KoB{Kp,`姙$JO궒jvż@r3`w\A%jSx+>m;5ا@._1:T#q]wrTC8r:lU4P}~Y]XwJ~b:YQϗLP-X_ֻа2$ݥC=~P]VҘLhu?S'\C:7"4dD*%9 Ogfe\OLoTy5Qkj.84,: t:_YON3˃:O/r犁3t!Psbty{aETu7nMѶ f+^Y6zHic?R%+C,γL =ZJ1H+,x^
I!u2{5x_@LI6[w5LN5:xXoEgf9tu=yùw=aґza*҃K`驪eP/y*sσn3N{ME\8g: *fz#W??L